Quarterly report pursuant to Section 13 or 15(d)

Segment and Geographic Information - Schedule of Financial Data by Reportable Segment (Details)

v3.24.3
Segment and Geographic Information - Schedule of Financial Data by Reportable Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Segment Reporting, Revenue Reconciling Item [Line Items]          
Revenue $ 74,877 $ 71,442 $ 194,336 $ 177,702  
Adjusted unallocated corporate expenses and software development (5,264) (5,336) (15,916) (17,281)  
Depreciation and amortization (1,279) (1,843) (4,432) (5,305)  
Stock-based compensation (5,345) (3,330) (15,434) (9,348)  
Change in fair value of warrant liabilities (299) 5,719 2,266 3,823  
Realized loss from sales of short-term investments 0 0 0 (95)  
Interest income 1,764 2,147 5,624 6,178  
Legal and regulatory advocacy fees (165) (217) (427) (640)  
Executive severance costs (140) 0 (140) (265)  
SOX readiness costs (220) (145) (302) (180)  
Contingent consideration compensation (earn-out) 0 (2,700) 0 (5,361)  
M&A transaction costs (85) 0 (169) 0  
Impairment of intangible assets 0 0 (5,759) 0  
Restructuring costs-Blade Europe (483) 0 (483) 0  
(Loss) income before income taxes (2,072) 418 (17,664) (22,578)  
Goodwill 42,952   42,952   $ 40,373
Operating Segments          
Segment Reporting, Revenue Reconciling Item [Line Items]          
Total Segment Adjusted EBITDA 9,444 6,123 17,508 5,896  
Passenger          
Segment Reporting, Revenue Reconciling Item [Line Items]          
Revenue 38,815 37,995 83,907 83,089  
Goodwill 27,412   27,412   27,045
Passenger | Operating Segments          
Segment Reporting, Revenue Reconciling Item [Line Items]          
Total Segment Adjusted EBITDA 5,593 2,777 3,724 (2,353)  
Medical          
Segment Reporting, Revenue Reconciling Item [Line Items]          
Revenue 36,062 33,447 110,429 94,613  
Goodwill 15,540   15,540   $ 13,328
Medical | Operating Segments          
Segment Reporting, Revenue Reconciling Item [Line Items]          
Total Segment Adjusted EBITDA $ 3,851 $ 3,346 $ 13,784 $ 8,249